Cytokines, platelet production and hemostasis
- 1 January 1997
- journal article
- Published by Taylor & Francis in Platelets
- Vol. 8 (2-3), 93-104
- https://doi.org/10.1080/09537109709169324
Abstract
A number of hematopoietic growth factors and other cytokines are capable of altering platelet production and function. Enhancement of these processes may be exploited to ameliorate bleeding propensity in thrombocytopenic patients. Under certain circumstances, cytokines may have adverse effects on the hemostatic system, potentially involved in thrombogenesis and atherogenesis. Inhibition of those cytokines may prove to be a useful experimental approach to investigate their potential pathophysiologic role.Keywords
This publication has 154 references indexed in Scilit:
- Interleukin 6 Induces the Expression of Vascular Endothelial Growth FactorJournal of Biological Chemistry, 1996
- Morphologic and ultrastructural evidence for interleukin‐6 induced platelet activationAmerican Journal of Hematology, 1995
- Thrombocytopenia in c-mpl-deficient miceScience, 1994
- Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.The Journal of Experimental Medicine, 1994
- Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on circulating plateletsAnnals of Hematology, 1992
- Interleukin-3 induces translocation and down-regulation of protein kinase C in human plateletsBiochemical and Biophysical Research Communications, 1992
- Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysisPediatric Nephrology, 1991
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Human megakaryocytes. II. Expression of platelet proteins in early marrow megakaryocytes.The Journal of Experimental Medicine, 1981